Julie Rytlewski
6PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 24, 2023
Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel.Bruno Paiva, Irene Manrique, Julie Rytlewski
|Feb 05, 2022
Publisher Correction: Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence.Wiebke Pruessmann, Julie Rytlewski, James Wilmott
|Aug 30, 2021
Impact of HLA type, age and chronic viral infection on peripheral T-cell receptor sharing between unrelated individuals.Sarah A Johnson, Spencer L Seale, Rachel M Gittelman
|Dec 11, 2020
Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence.Wiebke Pruessmann, Julie Rytlewski, James Wilmott
|Mar 15, 2019
Model to improve specificity for identification of clinically-relevant expanded T cells in peripheral blood.Julie Rytlewski, Shibing Deng, Tao Xie
|Feb 12, 2019
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.Timothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla
Pageof 1
Frequent Collaborators
3 joint publications
Paul Fields
2 joint publications
Richard A Scolyer
2 joint publications
Thomas S Kupper
2 joint publications
John F Thompson
2 joint publications
James Wilmott
1 joint publications
Aaron Y Mochizuki
1 joint publications
Joey R Orpilla
1 joint publications
Alexander H Lee
1 joint publications
Adam L Cohen
1 joint publications
Sarah A Johnson
